A NOVEL PHASE II TRIAL OF IPILIMUMAB, CARBOPLATIN AND ETOPOSIDE (ICE) FOR THE FIRST LINE TREATMENT OF EXTENSIVE STAGE SMALL CELL LUNG CANCER (SCLC)

被引：2
|
作者：
Ottensmeier, C. [1 ]
Galea, I. [2 ]
Cross, N. [3 ]
Maishman, T. [3 ]
Hamid, D. [3 ]
Cave, J. [4 ]
Wheater, M. [5 ]
Geldart, T. [6 ]
Mulatero, C. [7 ]
Potter, V. [8 ]
Danson, S. [9 ]
Woll, P. [10 ]
Griffiths, R. [11 ]
Nolan, L. [5 ]
机构：
[1] Southampton Univ Hosp NHS Trust, Canc Sci Div, Southampton, Hants, England
[2] Univ Hosp Southampton NHS Fdn Trust, Wessex Neurosci Ctr, Southampton, Hants, England
[3] Univ Southampton, Clin Trials Unit, Southampton, Hants, England
[4] Univ Hosp Southampton NHS FoundationTrust, Dept Med Oncol, Southampton, Hants, England
[5] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
[6] Royal Bournemouth Hosp, Bournemouth, Dorset, England
[7] Leeds Teaching Hosp NHS Trust, St James Univ Hosp, Leeds, W Yorkshire, England
[8] Nottingham Univ Hosp NHS Trust, Dept Oncol, Nottingham, England
[9] Weston Pk Hosp, Canc Res Ctr, Acad Unit Clin Oncol, Sheffield, S Yorkshire, England
[10] Weston Pk Hosp, Canc Res Ctr, Dept Oncol, Sheffield, S Yorkshire, England
[11] Clatterbridge Canc Ctr, Wirral, Merseyside, England
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu355.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1477P
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] Irinotecan plus carboplatin versus etoposide plus carboplatin in extensive disease small cell lung cancer: A randomized phase II trial.
    Schmittel, A
    von Weikersthal, LF
    Sebastian, M
    Link, H
    Schulze, K
    Thiel, E
    Keilhoz, U
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 632S - 632S
  • [32] Real-world evaluation of atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer
    Kim, Soo Han
    Jo, Eun Jung
    Mok, Jeongha
    Lee, Kwangha
    Kim, Ki Uk
    Park, Hye-Kyung
    Lee, Min Ki
    Eom, Jung Seop
    Kim, Mi-Hyun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (02): : 218 - 225
  • [33] Anlotinib combined with etoposide as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): Updated results from a phase II trial.
    Shen, Bo
    Wu, Yuan
    Shi, Lin
    Pan, Banzhou
    Yang, Kaihua
    Wang, Qiong
    Zhao, Weiqing
    Han, Zhengxiang
    Wang, Lifeng
    Feng, Jifeng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] First-Line Envafolimab plus Carboplatin-etoposide in Extensive-Stage Small-Cell Lung Cancer: a Single-Arm Phase II Study
    Sun, S.
    Zhao, X.
    Zhang, J.
    Zhang, X.
    Han, Q.
    Yan, X.
    Zhu, Y.
    Wang, J.
    Jiao, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S371 - S371
  • [35] Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC) - A multicenter phase II study
    Mavroudis, D
    Veslemes, M
    Kouroussis, C
    Tzanakis, N
    Ferdoutsis, E
    Toumbis, M
    Ziotopoulos, P
    Agelidou, M
    Tselepatiotis, E
    Kalbakis, K
    Souglakos, J
    Magkanas, E
    Samonis, G
    Georgoulias, V
    LUNG CANCER, 2002, 38 (01) : 59 - 63
  • [36] Gemcitabine and etoposide in chemonaive patients with extensive small cell lung cancer (SCLC): Preliminary phase II results
    vonPawel, J
    Gatzemeier, U
    Vansteenkiste, J
    Weynants, P
    Hanauske, A
    Bosquee, L
    Mansouri, K
    Znamensky, S
    Blatter, J
    Manegold, C
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1054 - 1054
  • [37] EQ-5D UTILITY ESTIMATES FROM THE IMPOWER 133 TRIAL OF TECENTRIQ plus CARBOPLATIN plus ETOPOSIDE VS. CARBOPLATIN plus ETOPOSIDE IN FIRST LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
    Orfanos, P.
    Castro, A. Y.
    Quach, C.
    VALUE IN HEALTH, 2019, 22 : S471 - S471
  • [38] A randomized phase II trial of pemetrexed (P) plus cisplatin (cis) or carboplatin (carbo) in extensive stage small cell lung cancer (ES-SCLC)
    Socinski, M
    Weissman, C
    Hart, L
    Beck, J
    Choksi, J
    Hanson, J
    Prager, D
    Bloss, L
    Ze, Y
    Obasaju, C
    LUNG CANCER, 2005, 49 : S328 - S329
  • [39] Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC
    Arriola, Edurne
    Wheater, Matthew
    Galea, Ian
    Cross, Nadia
    Maishman, Tom
    Hamid, Debbie
    Stanton, Louise
    Cave, Judith
    Geldart, Tom
    Mulatero, Clive
    Potter, Vannessa
    Danson, Sarah
    Woll, Pennella J.
    Griffiths, Richard
    Nolan, Luke
    Ottensmeier, Christian
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (09) : 1511 - 1521
  • [40] A randomized phase II trial of pemetrexed (P) plus cisplatin (cis) or carboplatin (carbo) in extensive stage small cell lung cancer (ES-SCLC).
    Socinski, MA
    Weissman, CH
    Hart, LL
    Beck, JT
    Choksi, JK
    Hanson, JP
    Prager, D
    Bloss, LP
    Ye, Z
    Obasaju, CK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 661S - 661S
12345